New England Capital Financial Advisors LLC Sells 773 Shares of Kenvue Inc. (NYSE:KVUE)

New England Capital Financial Advisors LLC decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 22.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,614 shares of the company’s stock after selling 773 shares during the period. New England Capital Financial Advisors LLC’s holdings in Kenvue were worth $56,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. GAMMA Investing LLC bought a new stake in shares of Kenvue during the 4th quarter valued at about $140,000. Parkside Financial Bank & Trust raised its stake in Kenvue by 20.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 18,258 shares of the company’s stock worth $393,000 after buying an additional 3,057 shares during the period. Illinois Municipal Retirement Fund raised its stake in Kenvue by 704.8% during the 4th quarter. Illinois Municipal Retirement Fund now owns 301,913 shares of the company’s stock worth $6,500,000 after buying an additional 264,397 shares during the period. New York State Common Retirement Fund raised its stake in Kenvue by 4.1% during the 4th quarter. New York State Common Retirement Fund now owns 2,368,935 shares of the company’s stock worth $51,003,000 after buying an additional 94,284 shares during the period. Finally, PDS Planning Inc acquired a new position in Kenvue during the 4th quarter worth approximately $265,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on KVUE shares. William Blair started coverage on Kenvue in a research note on Wednesday, April 3rd. They set a “market perform” rating on the stock. Royal Bank of Canada dropped their price target on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 9th. Sanford C. Bernstein started coverage on Kenvue in a research note on Thursday, April 11th. They set an “underperform” rating and a $18.00 price target on the stock. The Goldman Sachs Group initiated coverage on Kenvue in a research note on Friday, March 1st. They set a “neutral” rating and a $20.00 price target on the stock. Finally, JPMorgan Chase & Co. lowered their price objective on Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $24.85.

Kenvue Price Performance

Shares of KVUE stock traded down $0.22 during trading on Tuesday, hitting $19.36. The company’s stock had a trading volume of 19,764,634 shares, compared to its average volume of 16,661,875. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. The business has a fifty day moving average of $19.84 and a 200-day moving average of $20.16. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.03. The company had revenue of $3.67 billion during the quarter, compared to analyst estimates of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. Kenvue’s quarterly revenue was down 2.7% on a year-over-year basis. On average, research analysts expect that Kenvue Inc. will post 1.15 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.13%. The ex-dividend date was Tuesday, February 13th.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.